Amylyx Pharmaceuticals, Inc. <AMLX.O>: Baird raises target price to $52 from $28
AMLX•Related News
Gilead Chief Communications and Corporate Affairs Officer Johanna Mercier disposes of USD 3.86 million in common shares
GILD•
JBS offers to buy remaining Pilgrim’s Pride shares in all-stock deal at 2.086 exchange ratio
PPC•
Ascendis Pharma director Jean-Jacques Bienaime buys USD 492,079 of common shares
ASND•
PubMatic President of Engineering Mukul Kumar disposes of USD 136,402 in common shares
PUBM•
Press Digest-Financial Times - Aug 19
NVDA•